XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional paid-in capital
Accumulated other comprehensive loss
Retained earnings
Balance at beginning of period (in shares) at Jan. 01, 2022   41,148,870      
Balance at beginning of period at Jan. 01, 2022 $ 950,186 $ 411 $ 0 $ (28,897) $ 978,672
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   5,100      
Exercise of stock options 222 $ 0 222 0 0
Withholdings from vesting of restricted stock (in shares)   (70,452)      
Withholdings from vesting of restricted stock (6,623) $ 0 (6,623) 0 0
Restricted stock activity (in shares)   265,412      
Restricted stock activity 0 $ 3 (3) 0 0
Stock-based compensation expense 5,859 $ 0 5,859 0 0
Repurchase of common stock (in shares)   (793,008)      
Repurchase of common stock (74,496) $ (8) 545 0 (75,033)
Cash dividends declared and paid (30,573) 0 0 0 (30,573)
Comprehensive income 70,715 $ 0 0 2,782 67,933
Balance at end of period (in shares) at Apr. 02, 2022   40,555,922      
Balance at end of period at Apr. 02, 2022 915,290 $ 406 0 (26,115) 940,999
Balance at beginning of period (in shares) at Jan. 01, 2022   41,148,870      
Balance at beginning of period at Jan. 01, 2022 950,186 $ 411 0 (28,897) 978,672
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income $ 158,182        
Balance at end of period (in shares) at Oct. 01, 2022 38,456,219 38,456,219      
Balance at end of period at Oct. 01, 2022 $ 788,202 $ 385 0 (40,575) 828,392
Balance at beginning of period (in shares) at Apr. 02, 2022   40,555,922      
Balance at beginning of period at Apr. 02, 2022 915,290 $ 406 0 (26,115) 940,999
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   1,500      
Exercise of stock options 89 $ 0 89 0 0
Withholdings from vesting of restricted stock (in shares)   (705)      
Withholdings from vesting of restricted stock (58) $ 0 (58) 0 0
Restricted stock activity (in shares)   30,731      
Restricted stock activity 0 $ 0 0 0 0
Stock-based compensation expense 6,359 $ 0 6,359 0 0
Repurchase of common stock (in shares)   (1,272,354)      
Repurchase of common stock (101,810) $ (13) (6,390) 0 (95,407)
Cash dividends declared and paid (29,886) 0 0 0 (29,886)
Comprehensive income 30,882 $ 0 0 (6,088) 36,970
Balance at end of period (in shares) at Jul. 02, 2022   39,315,094      
Balance at end of period at Jul. 02, 2022 820,866 $ 393 0 (32,203) 852,676
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   7,850      
Exercise of stock options 465 $ 0 465 0 0
Withholdings from vesting of restricted stock (in shares)   (2,065)      
Withholdings from vesting of restricted stock (169) $ 0 (169) 0 0
Restricted stock activity (in shares)   12,459      
Restricted stock activity 0 $ 0 0 0 0
Stock-based compensation expense 5,003 $ 0 5,003 0 0
Repurchase of common stock (in shares)   (877,119)      
Repurchase of common stock (65,445) $ (8) (5,299) 0 (60,138)
Cash dividends declared and paid (29,103) 0 0 0 (29,103)
Comprehensive income $ 56,585 $ 0 0 (8,372) 64,957
Balance at end of period (in shares) at Oct. 01, 2022 38,456,219 38,456,219      
Balance at end of period at Oct. 01, 2022 $ 788,202 $ 385 0 (40,575) 828,392
Balance at beginning of period (in shares) at Dec. 31, 2022 37,692,132 37,692,132      
Balance at beginning of period at Dec. 31, 2022 $ 796,409 $ 377 0 (34,338) 830,370
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   1,400      
Exercise of stock options 83 $ 0 83 0 0
Withholdings from vesting of restricted stock (in shares)   (61,423)      
Withholdings from vesting of restricted stock (4,776) $ (1) (4,404) 0 (371)
Restricted stock activity (in shares)   303,015      
Restricted stock activity 0 $ 3 (3) 0 0
Stock-based compensation expense 4,343 $ 0 4,343 0 0
Repurchase of common stock (in shares)   (135,873)      
Repurchase of common stock (9,586) $ (1) 0 0 (9,585)
Cash dividends declared and paid (28,483) 0 0 0 (28,483)
Comprehensive income 39,922 0 0 3,926 35,996
Other (19) $ 0 (19) 0 0
Balance at end of period (in shares) at Apr. 01, 2023   37,799,251      
Balance at end of period at Apr. 01, 2023 $ 797,893 $ 378 0 (30,412) 827,927
Balance at beginning of period (in shares) at Dec. 31, 2022 37,692,132 37,692,132      
Balance at beginning of period at Dec. 31, 2022 $ 796,409 $ 377 0 (34,338) 830,370
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income $ 131,186        
Balance at end of period (in shares) at Sep. 30, 2023 36,969,967 36,969,967      
Balance at end of period at Sep. 30, 2023 $ 785,311 $ 370 0 (29,142) 814,083
Balance at beginning of period (in shares) at Apr. 01, 2023   37,799,251      
Balance at beginning of period at Apr. 01, 2023 797,893 $ 378 0 (30,412) 827,927
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Withholdings from vesting of restricted stock (in shares)   (932)      
Withholdings from vesting of restricted stock (61) $ 0 (61) 0 0
Restricted stock activity (in shares)   5,626      
Restricted stock activity 0 $ 0 0 0 0
Stock-based compensation expense 6,641 $ 0 6,641 0 0
Repurchase of common stock (in shares)   (449,481)      
Repurchase of common stock (30,336) $ (4) (6,294) 0 (24,038)
Cash dividends declared and paid (28,158) 0 0 0 (28,158)
Comprehensive income 29,316 0 0 5,449 23,867
Other (286) $ 0 (286) 0 0
Balance at end of period (in shares) at Jul. 01, 2023   37,354,464      
Balance at end of period at Jul. 01, 2023 775,009 $ 374 0 (24,963) 799,598
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   4,400      
Exercise of stock options 301 $ 0 301 0 0
Withholdings from vesting of restricted stock (in shares)   (2,359)      
Withholdings from vesting of restricted stock (170) $ 0 (170) 0 0
Restricted stock activity (in shares)   3,466      
Restricted stock activity 0 $ 0 0 0 0
Stock-based compensation expense 3,928 $ 0 3,928 0 0
Repurchase of common stock (in shares)   (390,004)      
Repurchase of common stock (27,570) $ (4) (3,786) 0 (23,780)
Cash dividends declared and paid (27,862) 0 0 0 (27,862)
Comprehensive income 61,948 0 0 (4,179) 66,127
Other $ (273) $ 0 (273) 0 0
Balance at end of period (in shares) at Sep. 30, 2023 36,969,967 36,969,967      
Balance at end of period at Sep. 30, 2023 $ 785,311 $ 370 $ 0 $ (29,142) $ 814,083